Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
The Annals of Pharmacotherapy|December 29, 2005
Analysis of severe adverse events related to the use of mifepristone as an abortifacientMargaret M Gary, Donna J Harrison
Online Journal of Public Health Informatics|October 22, 2019
Improving the Metrics and Data Reporting for Maternal Mortality: A Challenge to Public Health Surveillance and Effective PreventionJames Studnicki, David C Reardon, Donna J Harrison, et al.
Health Services Research and Managerial Epidemiology|August 27, 2020
Pregnancy Outcome Patterns of Medicaid-Eligible Women, 1999-2014: A National Prospective Longitudinal StudyJames Studnicki, John W Fisher, David C Reardon, et al.
Journal of Primary Care & Community Health|May 7, 2021
Estimating the Period Prevalence of Publicly Funded Abortion to Space Live Births, 1999 to 2014James Studnicki, John W Fisher, Tessa Longbons, et al.
Health Services Research and Managerial Epidemiology|April 26, 2019
Doctors Who Perform Abortions: Their Characteristics and Patterns of Holding and Using Hospital PrivilegesJames Studnicki, Tessa Longbons, John W Fisher, et al.
Issues in Law & Medicine|May 3, 2021
Deaths and Severe Adverse Events after the use of Mifepristone as an Abortifacient from September 2000 to February 2019Kathi Aultman, Christina A Cirucci, Donna J Harrison, et al.
Health Services Research and Managerial Epidemiology|November 15, 2021
A Longitudinal Cohort Study of Emergency Room Utilization Following Mifepristone Chemical and Surgical Abortions, 1999-2015James Studnicki, Donna J Harrison, Tessa Longbons, et al.
Health Services Research and Managerial Epidemiology|August 9, 2021
Estimating the Period Prevalence of Mothers Who Have Abortions: A Population Based Study of Inclusive Pregnancy OutcomesJames Studnicki, John W Fisher, Tessa Longbons, et al.
Pageof 2